S1439 The Overlooked Comorbidity: Impact of Esophageal Varices on Liver Cirrhosis-Related Mortality Trends in the U.S. Population from 1999-2023

Introduction: Cirrhosis is the 11th most significant cause of mortality in the United States as of 2023. Trends in mortality due to liver cirrhosis with esophageal varices remain inadequately documented. This study examines 25 years mortality trends for cirrhosis and esophageal varices among U.S. adults aged ≥45 years (1999 to 2023). Methods: We extracted mortality data from CDC WONDER database, including only adults aged ≥45 years coded for liver cirrhosis (International Classification of Diseases, Tenth Revision [ICD-10] K74) and esophageal varices (ICD-10 I85) from 1999 to 2023. Extracted data included age-adjusted mortality rates (AAMRs) categorized by sex, race/ethnicity, U.S. Census regions, and 2013 urbanization categories. Joinpoint regression analysis was used to calculate annual percent change (APC) with 95% confidence intervals and P-values to assess the mortality trends. A P-value of < 0.05 was considered statistically significant. Results: From 1999 to 2023, cirrhosis with esophageal varices caused 18,392 deaths, with an overall AAMR of 0.6 per 100,000 population and an upward trend from 2006 to onwards (APC: 2.2953, 95% CI: -5.6901 - 6.4933, P = 0.085983). Females exhibited a significant AAMR increase from 2008 to 2023 (APC: 3.73443, 95% CI: 2.4262-5.9046, P = 0.00). Among racial groups, Whites showed a significant post-2009 AAMR increase (APC: 2.84, 95% CI: 1.5070-5.0851, P = 0.00), while African Americans and Whites had declines from 1999 to 2009. Hispanics (1999-2006) and non-Hispanics (1999-2007) saw significant declines in AAMR (APC: -9.0381, 95% CI: -24.4016 to -3.3782, P = 0.00; APC: -6.7366 (95% CI: -11.3960 to -4.1338, P = 0.00), respectively. The Midwest and South had elevated AAMRs from 2006 to 2023, with APC = 1.2123 (95% CI: 0.1201 -2.6384, P = 0.036) and APC = 2.2918 (95% CI: 1.5172-3.3469, P = 0.00), West showing a significant post-2006 increase (APC: 2.13, 95% CI: 0.0113-8.2959, P = 0.049). Medium Metro (post-2006) and Micropolitan (post - 2005) areas had significant AAMR increases with APC: 1.3645 (95% CI: 0.0728-3.8164, P = 0.04) and APC: 1.9806, (95% CI: 0.9504-6.6945, P = 0.008), respectively. Conclusion: A marked rise in mortality from cirrhosis complicated by esophageal varices has risen significantly since 2018, with disproportionate increases among demographic and geographic regions. These results highlight critical gaps in the existing scientific understanding, requiring planned public health interventions, enhanced screening, and persistent surveillance to address escalating mortality in susceptible populations.

Publication Details

Journal
The American Journal of Gastroenterology
Published
2025-10-01
DOI
https://doi.org/10.14309/01.ajg.0001133216.35259.9f
Primary Topic
Liver Disease and Transplantation
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

S1439 The Overlooked Comorbidity: Impact of Esophageal Varices on Liver Cirrhosis-Related Mortality Trends in the U.S. Population from 1999-2023

The American Journal of Gastroenterology
Liver Disease and Transplantation
article

S1439 The Overlooked Comorbidity: Impact of Esophageal Varices on Liver Cirrhosis-Related Mortality Trends in the U.S. Population from 1999-2023

article en

Abstract

Introduction: Cirrhosis is the 11th most significant cause of mortality in the United States as of 2023. Trends in mortality due to liver cirrhosis with esophageal varices remain inadequately documented. This study examines 25 years mortality trends for cirrhosis and esophageal varices among U.S. adults aged ≥45 years (1999 to 2023). Methods: We extracted mortality data from CDC WONDER database, including only adults aged ≥45 years coded for liver cirrhosis (International Classification of Diseases, Tenth Revision [ICD-10] K74) and esophageal varices (ICD-10 I85) from 1999 to 2023. Extracted data included age-adjusted mortality rates (AAMRs) categorized by sex, race/ethnicity, U.S. Census regions, and 2013 urbanization categories. Joinpoint regression analysis was used to calculate annual percent change (APC) with 95% confidence intervals and P-values to assess the mortality trends. A P-value of < 0.05 was considered statistically significant. Results: From 1999 to 2023, cirrhosis with esophageal varices caused 18,392 deaths, with an overall AAMR of 0.6 per 100,000 population and an upward trend from 2006 to onwards (APC: 2.2953, 95% CI: -5.6901 - 6.4933, P = 0.085983). Females exhibited a significant AAMR increase from 2008 to 2023 (APC: 3.73443, 95% CI: 2.4262-5.9046, P = 0.00). Among racial groups, Whites showed a significant post-2009 AAMR increase (APC: 2.84, 95% CI: 1.5070-5.0851, P = 0.00), while African Americans and Whites had declines from 1999 to 2009. Hispanics (1999-2006) and non-Hispanics (1999-2007) saw significant declines in AAMR (APC: -9.0381, 95% CI: -24.4016 to -3.3782, P = 0.00; APC: -6.7366 (95% CI: -11.3960 to -4.1338, P = 0.00), respectively. The Midwest and South had elevated AAMRs from 2006 to 2023, with APC = 1.2123 (95% CI: 0.1201 -2.6384, P = 0.036) and APC = 2.2918 (95% CI: 1.5172-3.3469, P = 0.00), West showing a significant post-2006 increase (APC: 2.13, 95% CI: 0.0113-8.2959, P = 0.049). Medium Metro (post-2006) and Micropolitan (post - 2005) areas had significant AAMR increases with APC: 1.3645 (95% CI: 0.0728-3.8164, P = 0.04) and APC: 1.9806, (95% CI: 0.9504-6.6945, P = 0.008), respectively. Conclusion: A marked rise in mortality from cirrhosis complicated by esophageal varices has risen significantly since 2018, with disproportionate increases among demographic and geographic regions. These results highlight critical gaps in the existing scientific understanding, requiring planned public health interventions, enhanced screening, and persistent surveillance to address escalating mortality in susceptible populations.

The American Journal of GastroenterologyVol. 120(10S2)
Sustainable cities and communities
Openalex Percentile: Top 34%
Liver Disease and Transplantation
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.